These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 20130720)

  • 1. Osteoporosis prophylaxis prescribing patterns in ophthalmology patients treated with long-term corticosteroids.
    Walker RA; Hall RB; Pekush RD; Taylor-Gjevre RM
    Can J Ophthalmol; 2010 Feb; 45(1):81-2. PubMed ID: 20130720
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of steroid-induced osteoporosis is not unique to ophthalmology.
    Pope J; McKeown E
    Can J Ophthalmol; 2010 Feb; 45(1):10-2. PubMed ID: 20130702
    [No Abstract]   [Full Text] [Related]  

  • 3. Current practices for the prophylaxis against bone mineral density loss in patients with autoimmune blistering disease treated with corticosteroids: an expert survey.
    Amber KT; Grando SA
    J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):e416-e418. PubMed ID: 29705983
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary osteoporosis: Inhaled corticosteroids induced osteoporosis in respiratory diseases].
    Ieda Y; Nagasaka Y
    Clin Calcium; 2007 Jun; 17(6):955-62. PubMed ID: 17548937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in improving the quality of osteoporosis care for long-term glucocorticoid users: a prospective randomized trial.
    Curtis JR; Westfall AO; Allison J; Becker A; Melton ME; Freeman A; Kiefe CI; MacArthur M; Ockershausen T; Stewart E; Weissman N; Saag KG
    Arch Intern Med; 2007 Mar; 167(6):591-6. PubMed ID: 17389291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Referral patterns to an osteoporosis clinic for dermatology patients undergoing prolonged corticosteroid therapy.
    Mowad C; Cohen SF; Flandry Fussell N; Martin RE; Ellison CA
    J Am Acad Dermatol; 2018 Mar; 78(3):591-592. PubMed ID: 29447676
    [No Abstract]   [Full Text] [Related]  

  • 7. Polymyalgia rheumatica and giant-cell arteritis.
    Praderio L; Di Comite G; Saporiti N
    N Engl J Med; 2002 Dec; 347(25):2083-5; author reply 2083-5. PubMed ID: 12494941
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prevention of cortisone-induced osteoporosis].
    Trombetti A; Ferrari S; Stoermann-Chopard C; Rizzoli R
    Praxis (Bern 1994); 2004 Mar; 93(11):407-14. PubMed ID: 15061108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low dose corticosteroid associated osteoporosis in rheumatoid arthritis and its prophylaxis and treatment: bones of contention.
    Dequeker J; Westhovens R
    J Rheumatol; 1995 Jun; 22(6):1013-9. PubMed ID: 7674223
    [No Abstract]   [Full Text] [Related]  

  • 10. Iatrogenic morbidity accompanying suppression of temporal arteritis by adrenal corticosteroids.
    Rubinow A; Brandt KD; Cohen AS; Sack B
    Ann Ophthalmol; 1984 Mar; 16(3):258-60, 262, 264-5. PubMed ID: 6712068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of polymyalgia rheumatica].
    Gasparini M
    Clin Ter; 1984 Jul; 110(1):55-63. PubMed ID: 6237847
    [No Abstract]   [Full Text] [Related]  

  • 12. Bisphosphonates routine in prevention of post-transplant osteoporosis?
    Höfle G; Holzmüller H; Drexel H
    J Bone Miner Res; 2005 Aug; 20(8):1482; author reply 1483. PubMed ID: 16007347
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteoporosis after long-term corticosteroid treatment of giant cell arteritis.
    Andersson R; Rundgren A; Rosengren K; Bengtsson BA; Malmvall BE; Mellström D
    J Intern Med; 1990 Jun; 227(6):391-5. PubMed ID: 2351926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone disease in asthma.
    Walsh LJ; Tattersfield AE
    Br J Hosp Med; 1997 Apr 16-May 6; 57(8):390-3. PubMed ID: 9296791
    [No Abstract]   [Full Text] [Related]  

  • 15. Osteoporosis prophylaxis during corticosteroid treatment.
    Chattopadhyay I; Showkathali AR; Jain AK
    Postgrad Med J; 2002 Sep; 78(923):572. PubMed ID: 12357030
    [No Abstract]   [Full Text] [Related]  

  • 16. [Bisphosphonate therapy in corticoid-induced osteoporosis].
    Ringe JD
    Dtsch Med Wochenschr; 1997 Oct; 122(40):1231. PubMed ID: 9378048
    [No Abstract]   [Full Text] [Related]  

  • 17. [Decalcification of bone due to corticosteroids].
    Lems WF; Jacobs JW; Raymakers JA; Bijlsma JW
    Ned Tijdschr Geneeskd; 1992 Aug; 136(33):1595-9. PubMed ID: 1407091
    [No Abstract]   [Full Text] [Related]  

  • 18. Corticosteroids: no drug prevention of fractures needed.
    Prescrire Int; 2009 Aug; 18(102):175. PubMed ID: 19746563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access to bone densitometry increases general practitioners' prescribing for osteoporosis in steroid treated patients.
    Dolan AL; Koshy E; Waker M; Goble CM
    Ann Rheum Dis; 2004 Feb; 63(2):183-6. PubMed ID: 14722208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological prevention of osteoporosis in patients on corticosteroid medication].
    Lems WF; Jacobs JW; Netelenbos JC; Dijkmans BA; Bijlsma JW
    Ned Tijdschr Geneeskd; 1998 Aug; 142(34):1904-8. PubMed ID: 9856175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.